Neurocrine Biosciences, Inc. (NBIX)
167.75
-0.78
(-0.47%)
USD |
NASDAQ |
Jul 01, 16:00
167.75
0.00 (0.00%)
After-Hours: 18:26
Neurocrine Biosciences Price : 167.75 for July 1, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 30, 2026 | 170.66 | 171.50 | 168.24 | 168.54 | 1.076M |
| Jun 29, 2026 | 168.87 | 171.43 | 167.90 | 170.00 | 1.351M |
| Jun 26, 2026 | 163.59 | 169.56 | 163.12 | 168.52 | 1.953M |
| Jun 25, 2026 | 165.84 | 168.07 | 163.68 | 164.18 | 783664.0 |
| Jun 24, 2026 | 163.43 | 168.58 | 162.34 | 166.06 | 1.362M |
| Jun 23, 2026 | 161.62 | 163.53 | 160.42 | 161.44 | 1.076M |
| Jun 22, 2026 | 161.17 | 161.79 | 159.32 | 161.62 | 1.009M |
| Jun 18, 2026 | 160.01 | 161.33 | 156.31 | 158.29 | 2.718M |
| Jun 17, 2026 | 156.62 | 160.02 | 155.66 | 159.00 | 1.038M |
| Jun 16, 2026 | 160.61 | 161.66 | 155.30 | 156.42 | 934446.0 |
| Jun 15, 2026 | 159.89 | 160.55 | 156.70 | 159.51 | 1.244M |
| Jun 12, 2026 | 162.04 | 162.97 | 159.44 | 159.76 | 1.055M |
| Jun 11, 2026 | 161.59 | 164.04 | 160.18 | 162.71 | 764865.0 |
| Jun 10, 2026 | 167.80 | 169.39 | 160.72 | 160.86 | 1.097M |
| Jun 09, 2026 | 164.89 | 166.43 | 160.88 | 165.24 | 1.099M |
| Jun 08, 2026 | 163.88 | 165.40 | 162.22 | 163.12 | 804520.0 |
| Jun 05, 2026 | 167.53 | 168.00 | 163.11 | 163.88 | 1.050M |
| Jun 04, 2026 | 165.23 | 169.57 | 164.52 | 167.35 | 1.302M |
| Jun 03, 2026 | 155.56 | 165.81 | 155.12 | 165.11 | 1.942M |
| Jun 02, 2026 | 160.40 | 160.40 | 154.06 | 154.84 | 1.039M |
| Jun 01, 2026 | 159.36 | 161.80 | 157.44 | 161.00 | 1.221M |
| May 29, 2026 | 156.71 | 159.08 | 155.43 | 158.30 | 1.908M |
| May 28, 2026 | 155.75 | 157.84 | 154.32 | 156.39 | 1.068M |
| May 27, 2026 | 156.74 | 157.62 | 154.48 | 155.83 | 708584.0 |
| May 26, 2026 | 158.00 | 158.24 | 155.66 | 155.73 | 984356.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 209.80 |
| Amgen, Inc. | 361.16 |
| Iovance Biotherapeutics, Inc. | 3.975 |
| Voyager Therapeutics, Inc. | 3.61 |
| Incyte Corp. | 113.83 |
Price Related Metrics
| PE Ratio | 25.79 |
| PS Ratio | 5.550 |
| PEG Ratio | 0.2139 |
| Price to Book Value | 4.953 |
| Price to Free Cash Flow | 20.71 |
| Earnings Yield | 3.88% |
| Market Cap | 16.88B |
| PEGY Ratio | 0.2139 |
| Operating PE Ratio | 21.56 |
| Normalized PE Ratio | 26.16 |